Can anyone with institutional access help me get PDFs of these restricted access journal articles? I’m usually pretty good at tracking down what I need, but these have proved elusive. The ones I’m particularly interested in at the moment are marked with ‼️. Any assistance would be appreciated. If you can help, please email me.
(Updated: April 24, 2025)
Achar, C., Agrawal, N., & Lock, K. (2025). From Stigma to Support: ‘Black-Owned’ Labels and Expertise Stereotypes in Cannabis and Psychedelics Markets. Journal of Consumer Research, ucaf022. https://doi.org/10.1093/jcr/ucaf022
Aday, J. S., Bloesch, E. K., Davis, A. K., Domoff, S. E., Scherr, K., Woolley, J. D., & Davoli, C. C. (2024). Increases in Aesthetic Experience Following Ayahuasca Use: A Prospective, Naturalistic Study. Journal of Humanistic Psychology, 00221678241230609. https://doi.org/10.1177/00221678241230609
Aparicio-Terrés, R., López-Mochales, S., Díaz-Andreu, M., & Escera, C. (2025). The strength of neural entrainment to electronic music correlates with proxies of altered states of consciousness. Frontiers in Human Neuroscience, 19. https://doi.org/10.3389/fnhum.2025.1574836
Brøns, C. (2025). The Scent of Ancient Greco-Roman Sculpture. Oxford Journal of Archaeology, ojoa.12321. https://doi.org/10.1111/ojoa.12321
Cirillo, M. A. (2025). Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing? Journal of Humanistic Psychology, 00221678251321040. https://doi.org/10.1177/00221678251321040
Davis, E. (2012). Return Trip: The Re-Enchantment of Psychedelics. Mind and Matter, 10(2), 185–194. https://www.ingentaconnect.com/content/imp/mm/2012/00000010/00000002/art00004
Dutheil, S., Lehmann, V. E., Awadallah, N., John, N., Zhang, L., Yao, W., Li, P., Snyder, G., & Davis, R. (2025). 319. Discovery and Development of ITI-1549: A Novel Serotonin 5-HT2A Agonist, Non-Hallucinogenic Neuroplastogen, for the Treatment of Neuropsychiatric Disorders. Biological Psychiatry, 97(9), S227. https://doi.org/10.1016/j.biopsych.2025.02.557
Falchi-Carvalho, M., Palhano-Fontes, F., Wießner, I., Barros, H., Bolcont, R., Laborde, S., Ruschi B. Silva, S., Montanini, D., C. Barbosa, D., Teixeira, E., Florence-Vilela, R., Almeida, R., K. A. De Macedo, R., Arichelle, F., J. Pantrigo, É., V. Costa-Macedo, J., Da Cruz Nunes, J. A., De Araújo Costa Neto, L. A., Nunes Ferreira, L. F., … B. Araujo, D. (2025). Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: A phase 2a clinical trial in treatment-resistant depression. Neuropsychopharmacology. https://doi.org/10.1038/s41386-025-02091-6
Forstmann, M., & Sagioglou, C. (2025). The Content, Consistency and Accuracy of Stereotypes About Recreational Users of Various Psychoactive Substances. European Journal of Social Psychology, ejsp.3162. https://doi.org/10.1002/ejsp.3162
Gatling, S., Threadgill, E., & Conners, K. (2025). Structured Sensory Stimulation for Children with Disorders of Consciousness. Archives of Physical Medicine and Rehabilitation, 106(4), e89. https://doi.org/10.1016/j.apmr.2025.01.232
Gibbs, A. C. (2022). Aesthetics of Music, on Psychedelics. Mind and Matter, 20(2), 177–194. https://www.ingentaconnect.com/content/imp/mm/2022/00000020/00000002/art00002
Glatfelter, G., Walther, D., Maitland, A. D., Partilla, J., Chadeayne, A. R., Manke, D. R., & Baumann, M. H. (2025). Serotonin Transporter Activity Modulates the Psychedelic-Like Effects of 4-methoxy-N-methyl-N-isopropyltryptamine and Related Analogs in Mice (Abstract ID: 166221). The Journal of Pharmacology and Experimental Therapeutics, 392(3), 101348. https://doi.org/10.1016/j.jpet.2024.101348
Gonzalez-Rodriguez, D. (2025). Dynamic Non-Dualism and Processual Animism: Reframing Consciousness and Complexity Through Process-Oriented Ontology. Philosophia. https://doi.org/10.1007/s11406-025-00823-y
Grady, P., Cogan, A., Kozlowski, A., O’Brien, K., Bodien, Y., Mallinson, T., Giacino, J., & Weaver, J. (2025). Going Beyond State of Consciousness: Using Responsiveness Indices to Evaluate Change in Patients with Disorders of Consciousness. Archives of Physical Medicine and Rehabilitation, 106(4), e35. https://doi.org/10.1016/j.apmr.2025.01.091
Iengo, I. (2025). Naples, 2032: Visionary Fragments of the Eco‐Transfeminist City. Antipode, 57(3), 996–1016. https://doi.org/10.1111/anti.70000
‼️ Kruger, D. J., Argyri, E. K., Mogilski, J. K., Herberholz, M., Barron, J., Aday, J. S., & Boehnke, K. F. (2025b). Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics: A Mixed-Methods Investigation. The Journal of Sex Research, 1–12. https://doi.org/10.1080/00224499.2025.2479197
LeBlanc, A. R. (2025). Hypnosis, religious experience, and the predictive brain. Journal of Theoretical and Philosophical Psychology, 45(2), TBA. https://doi.org/10.1037/teo0000318
Lemmens, P. (2024). Expanding the Noosphere and Re-elevating the Anthropos: The Neganthropocene and the Psychedelic Pharmakon. Philosophy Today, 68(3), 543–566. https://doi.org/10.5840/philtoday202485537
‼️ Leonard, D., & Brooks, T. R. (2025). Peak Experiences Matter. Journal of Humanistic Psychology, 00221678251330066. https://doi.org/10.1177/00221678251330066
‼️ Letheby, C. (2015). The Philosophy of Psychedelic Transformation. Journal of Consciousness Studies, 22(9–10), 170–193. https://www.ingentaconnect.com/content/imp/jcs/2015/00000022/F0020009/art00011
Mckilliam, A. (2025). Explanation, understanding, and the methodological problem in consciousness science. Synthese, 205(142). https://doi.org/10.1007/s11229-025-05001-x
Rasmussen, K., Leach, P., Prince, R., Agrawal, R., Gillie, D., Mungenast, A., McTighe, S., Chytil, M., Meyer, R., Koenig, A., Rus, M., Olson, D., & Salinas, E. (2025). 569. Preclinical Pharmacology of DLX-2270: A Novel, Next Generation, Non-Hallucinogenic Neuroplastogen With the Potential for Treating Schizophrenia. Biological Psychiatry, 97(9), S333. https://doi.org/10.1016/j.biopsych.2025.02.808
Reiche, S., Hirschfeld, T., Gröticke, A. L., Traub, M., Hafiz, N. J., Haas, R., Sedlaczek, L., Ortlieb, L., Leistenschneider, G., Basedow, L. A., Lohse, A., Bermpohl, F., Riemer, T. G., & Majić, T. (2025). Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111353. https://doi.org/10.1016/j.pnpbp.2025.111353
Seillier, L., Čechová, B., Seillier, A., & Šlamberová, R. (2025). Psilocybin has a narrow therapeutic window as an antidepressant treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111368. https://doi.org/10.1016/j.pnpbp.2025.111368
Shao, L.-X., Liao, C., Davoudian, P. A., Savalia, N. K., Jiang, Q., Wojtasiewicz, C., Tan, D., Nothnagel, J. D., Liu, R.-J., Woodburn, S. C., Bilash, O. M., Kim, H., Che, A., & Kwan, A. C. (2025). Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors. Nature. https://doi.org/10.1038/s41586-025-08813-6
Thiry, M., & Milnes, A. (2025). Palaeolithic Map Engraved for Staging Water Flows in a Paris Basin Shelter. Oxford Journal of Archaeology, 44(1), 2–26. https://doi.org/10.1111/ojoa.12316
‼️ Viña, S. M. (2025). American Indian areas and psychedelics: A test of the minorities’ diminished psychedelic returns. Journal of Rural Mental Health. https://doi.org/10.1037/rmh0000302